These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7580190)

  • 1. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium valproate on behavioral disturbances in elderly outpatients with dementia.
    Mizukami K; Hatanaka K; Ishii T; Iwakiri M; Sodeyama N; Tanaka Y; Asada T
    Geriatr Gerontol Int; 2010 Oct; 10(4):324-6. PubMed ID: 20887626
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances.
    Kunik ME; Puryear L; Orengo CA; Molinari V; Workman RH
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):29-34. PubMed ID: 9489578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
    Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled study of divalproex sodium for agitation in dementia.
    Porsteinsson AP; Tariot PN; Erb R; Cox C; Smith E; Jakimovich L; Noviasky J; Kowalski N; Holt CJ; Irvine C
    Am J Geriatr Psychiatry; 2001; 9(1):58-66. PubMed ID: 11156753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.
    Porsteinsson AP; Tariot PN; Jakimovich LJ; Kowalski N; Holt C; Erb R; Cox C
    Am J Geriatr Psychiatry; 2003; 11(4):434-40. PubMed ID: 12837672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of behavioral disturbances associated with dementia.
    Modai I
    Isr J Psychiatry Relat Sci; 1999; 36(1):1-4. PubMed ID: 10389355
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics, elderly patients, and mortality risk.
    Citrome L
    South Med J; 2007 Oct; 100(10):964-5. PubMed ID: 17943033
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Franco KN; Messinger-Rapport B
    J Am Med Dir Assoc; 2006 Mar; 7(3):201-2. PubMed ID: 16503315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics for agitation in dementia.
    Ton J; Ramji J; Allan GM
    Can Fam Physician; 2018 May; 64(5):369. PubMed ID: 29760258
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.